BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30197330)

  • 1. Immunohistochemical study of the expression of human chorionic gonadotropin-β in salivary gland tumors.
    Meda S; Reginald BA; Reddy BS
    J Cancer Res Ther; 2018; 14(5):952-956. PubMed ID: 30197330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implication of CD166 expression in salivary gland tumor.
    Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
    Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
    Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
    Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
    Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
    Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of DNA content in salivary gland tumors].
    Yáñez M; Roa I; Villaseca M; Fuentealba P
    Rev Med Chil; 1997 Oct; 125(10):1177-81. PubMed ID: 9609036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
    Toper MH; Sarioglu S
    Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ras-P21 in salivary gland tumors.
    Kusama K; Chu L; Suzuki T; Okutsu S; Kudo I; Moro I
    Adv Exp Med Biol; 1995; 371B():1187-90. PubMed ID: 7502781
    [No Abstract]   [Full Text] [Related]  

  • 8. Overexpression of CDC7 in malignant salivary gland tumors correlates with tumor differentiation.
    Jaafari-Ashkavandi Z; Ashraf MJ; Abbaspoorfard AA
    Braz J Otorhinolaryngol; 2019; 85(2):144-149. PubMed ID: 29339028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
    Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
    Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands.
    Kiyoshima T; Shima K; Kobayashi I; Matsuo K; Okamura K; Komatsu S; Rasul AM; Sakai H
    Oral Oncol; 2001 Apr; 37(3):315-22. PubMed ID: 11287288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFβ signaling pathway in salivary gland tumors.
    Gomes ÁNM; Oliveira KK; Marchi FA; Bettim BB; Germano JN; Gonçalves Filho J; Pinto CAL; Lourenço SV; Coutinho-Camillo CM
    Arch Oral Biol; 2024 Jun; 162():105943. PubMed ID: 38479278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
    Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
    Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
    Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
    Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
    Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
    Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.
    Bubola J; MacMillan CM; Demicco EG; Chami RA; Chung CT; Leong I; Marrano P; Onkal Z; Swanson D; Veremis BM; Weinreb I; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2021 Oct; 60(10):695-708. PubMed ID: 34176176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
    Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
    Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of SIX1, ME2, and AP2M1 in adenoid cystic carcinoma and mucoepidermoid carcinoma.
    Wu CC; Li H; Xiao Y; Deng WW; Sun ZJ
    Oral Dis; 2020 Nov; 26(8):1687-1695. PubMed ID: 32564485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
    Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
    Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
    Stenman G
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
    Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
    Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.